Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umut Sarpel

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Annals of Surgical Oncology|August 28, 2025
Intraperitoneal Chemotherapy: A Call to Study Reproductive Safety for Healthcare WorkersPrincy Gupta, Elizabeth L Godfrey, Kurt S Schultz, et al.
Annals of Surgical Oncology|December 21, 2023
Preoperative Frailty and Malnutrition in Surgical Oncology Patients Predicts Higher Postoperative Adverse Events and Worse Survival: Results of a Blinded, Prospective TrialNazanin Khajoueinejad, Elad Sarfaty, Allen T Yu, et al.
The Oncologist|June 4, 2026
Multidisciplinary Clinics in Cancer-Models, Metrics, and Meaning: A ReviewSeohyuk Lee, Jim W Doolin, David E Avigan, et al.
Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal MetastasesKurt S Schultz, Varun V Bansal, Michael M Wach, et al.
Cancer|June 25, 2025
Consensus guideline for the management of colorectal cancer with peritoneal metastasesKurt S Schultz, Varun V Bansal, Michael M Wach, et al.
Annals of Surgical Oncology|August 26, 2024
Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy: Results of Phase I of the PRECINCT Study in 707 PatientsAditi Bhatt, Laurent Villeneuve, Armando Sardi, et al.
JAMA|April 20, 2023
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical TrialMichael I D'Angelica, Ryan J Ellis, Jason B Liu, et al.
The Lancet. Gastroenterology & Hepatology|January 22, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trialThomas U Marron, Maria Isabel Fiel, Pauline Hamon, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Annals of Surgical Oncology|August 28, 2025
Intraperitoneal Chemotherapy: A Call to Study Reproductive Safety for Healthcare WorkersPrincy Gupta, Elizabeth L Godfrey, Kurt S Schultz, et al.
Annals of Surgical Oncology|December 21, 2023
Preoperative Frailty and Malnutrition in Surgical Oncology Patients Predicts Higher Postoperative Adverse Events and Worse Survival: Results of a Blinded, Prospective TrialNazanin Khajoueinejad, Elad Sarfaty, Allen T Yu, et al.
The Oncologist|June 4, 2026
Multidisciplinary Clinics in Cancer-Models, Metrics, and Meaning: A ReviewSeohyuk Lee, Jim W Doolin, David E Avigan, et al.
Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal MetastasesKurt S Schultz, Varun V Bansal, Michael M Wach, et al.
Cancer|June 25, 2025
Consensus guideline for the management of colorectal cancer with peritoneal metastasesKurt S Schultz, Varun V Bansal, Michael M Wach, et al.
Annals of Surgical Oncology|August 26, 2024
Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy: Results of Phase I of the PRECINCT Study in 707 PatientsAditi Bhatt, Laurent Villeneuve, Armando Sardi, et al.
JAMA|April 20, 2023
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical TrialMichael I D'Angelica, Ryan J Ellis, Jason B Liu, et al.
The Lancet. Gastroenterology & Hepatology|January 22, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trialThomas U Marron, Maria Isabel Fiel, Pauline Hamon, et al.
Pageof 12